Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study by Wagner Lars M, Villablanca Judith G, Stewart Clinton F, Crews Kristine R, Groshen Susan, Reynolds C Patrick, Park Julie R, Maris John M, Hawkins Randall A, Daldrup-Link Heike E, Jackson Hollie A, Matthay Katherine K in Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2009).

[PMID: 19171709] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.